Ensign Peak Advisors, Inc Abbott Laboratories Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 3,236,801 shares of ABT stock, worth $375 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

3,236,801

Previous 3,112,410 4.0%

Holding current value

$375 Million

Previous $323 Million 14.11%

% of portfolio

0.66%

Previous 0.6%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $12.4 Million - $14.7 Million	124,391 Added 4.0%	3,236,801 $369 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.04 Million - $1.16 Million	10,278 Added 0.33%	3,112,410 $323 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $35.5 Million - $39.2 Million	-323,699 Reduced 9.45%	3,102,132 $353 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $56.8 Million - $69.5 Million	-629,292 Reduced 15.52%	3,425,831 $377 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $16.8 Million - $20.1 Million	-175,422 Reduced 4.15%	4,055,123 $393 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $10.3 Million - $11.5 Million	-102,517 Reduced 2.37%	4,230,545 $461 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $30.3 Million - $35.6 Million	312,414 Added 7.77%	4,333,062 $439 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $846,129 - $992,639	-8,901 Reduced 0.22%	4,020,648 $442 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $7.48 Million - $8.66 Million	77,270 Added 1.96%	4,029,549 $390 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $15.9 Million - $19.3 Million	156,071 Added 4.11%	3,952,279 $429 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $27.4 Million - $33.5 Million	240,606 Added 6.77%	3,796,208 $449 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $17.4 Million - $21.3 Million	150,914 Added 4.43%	3,555,602 $500 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $8.5 Million - $9.4 Million	-72,839 Reduced 2.09%	3,404,688 $402 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $1.35 Million - $1.58 Million	-12,717 Reduced 0.36%	3,477,527 $403 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $3.61 Million - $4.26 Million	-33,188 Reduced 0.94%	3,490,244 $418 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $8.02 Million - $8.74 Million	-76,386 Reduced 2.12%	3,523,432 $386 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.91 Million - $3.53 Million	-31,736 Reduced 0.87%	3,599,818 $392 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $14 Million - $17.9 Million	-182,210 Reduced 4.78%	3,631,554 $332 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $3.24 Million - $4.74 Million	-51,609 Reduced 1.34%	3,813,764 $301 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $303 Million - $338 Million	3,865,373 New	3,865,373 $336 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Abbott Laboratories Transaction History